{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Summarized using summary statistics, such as the mean, median, counts and proportion. Ninety-five percent confidence intervals will be constructed and selected results will be illustrated using figures and plots.","groups":[{"description":"Patients receive belinostat IV over 30 minutes on days 1-5. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.\n\nbelinostat: Given IV","id":"OG000","title":"Treatment (Enzyme Inhibitor Therapy)"}],"populationDescription":"No participants had an objective response out of the 32 patients analyzed.","reportingStatus":"POSTED","timeFrame":"From the time measurement criteria are met for CR or PR (whichever is first recorded) until the first date that recurrent or progressive disease is objectively documented, assessed up to 5 years","title":"Duration of Response","type":"SECONDARY"}